Across
- 2. Where science meets the stock market
- 5. Gradual adjustment to reach a target dose
- 7. Global pharmaceutical company headquartered in Japan
- 9. Startup operating quietly before announcing its breakthrough
- 12. Pharma’s dream product
- 13. What a bond pays – or what crops do
- 15. Place where bulls and bears meet
- 18. Drug candidate investors hope becomes valuable
- 19. Return on espresso?
- 20. Short for oncology
- 21. Genetic Courier
- 25. Financial gain after expenses
- 26. Medicine powered mostly by belief
- 27. Startup strategic shift
- 29. Investor who sees green everywhere
- 30. Molecule seeking receptor companionship
- 33. Startup creature investors hunt
- 35. Investor bragging rights
- 37. Research funding award
- 39. Inactive ingredient in a drug formulation
- 40. People everyone ultimately works for
Down
- 1. Investor fuel for new ideas
- 3. What drugs hit without darts
- 4. Enzyme that transfers phosphate groups
- 6. Study of an organism’s complete DNA set
- 7. Investigation with lab coats involved
- 8. Ambitious scientific bet with massive upside
- 10. Clinical experiment
- 11. Protein that tells immune cells what to do
- 14. Legal shield for new discoveries
- 16. Time before the funding plane must land
- 17. Specific part of an antigen recognized by antibodies
- 22. Wallstreet Debut
- 23. How well a treatment works under ideal conditions
- 24. Where regulators play hide & seek with the details
- 28. FDA deadline that keeps biotech executives awake at night
- 31. Category of antibody
- 32. Something celebrated long before results arrive
- 34. Cancer-causing gene
- 36. List of drugs investors are nervously watching
- 38. Regulatory application allowing human clinical trials